The Additional Ventures Translational Accelerator was created to break through the “valley of death” in single ventricle translational research. By removing early-stage roadblocks and equipping investigators with funding and strategic expertise, the Accelerator helps translate high-potential discoveries to clinical realities.

Virtually no medical devices are specifically designed or engineered with single ventricle patients in mind. The Additional Ventures-CTIP Device Innovation Award is designed to change that. By fueling bold, early-stage device concepts purpose-built for single-ventricle patients at every stage of treatment, this Award tackles this gap head on and accelerates life-saving innovation where it is needed most.